Bank Of New York Mellon Corp Decibel Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$2.08 - $4.79 $84,217 - $193,942	40,489 New	40,489 $122 Million
Q4 2022 Feb 14, 2023	BUY	$1.86 - $3.54 $51,581 - $98,171	27,732 New	27,732 $56,000
Q3 2022 Nov 14, 2022	BUY	$3.82 - $5.61 $1,612 - $2,367	422 Added 1.55%	27,732 $95,000
Q2 2021 Aug 11, 2021	BUY	$6.39 - $11.51 $96,597 - $173,996	15,117 Added 123.98%	27,310 $234,000
Q1 2021 May 13, 2021	BUY	$10.56 - $19.9 $128,758 - $242,640	12,193 New	12,193 $138,000

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.